SOS1 and chronic myelogenous leukemia, BCR-ABL1 positive: It is also relevant to mention that the ablation of SOS1 only produced a significant delay with respect to CML when SOS1 was ablated in the early stages of CML disease development (6 months of age) (Figure 2A).